July 8, 2008 - Foothills Medical Centre, a leading medical centre for treating patients with cardiac rhythm abnormalities in Calgary, Alberta, has become the first facility in Canada to use the new Evolution Mechanical Dilator Sheath Set from Cook Medical for the removal of pacemaker leads, reportedly simplifying this potentially challenging medical procedure.

TRUMPF Medical Systems Inc. offers an in-light high definition (HD) operating room camera, the TruVidia HD, which captures and transmits razor sharp, true-to-life images.

The camera offers a 1,080 line horizontal resolution and 2 million pixels. The images are said to be more than twice as clear as those available from standard definition cameras.

July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of Interventional Cardiology demonstrate that the Genous Bio-engineered R stent has better outcomes when compared to drug-eluting stents.

July 7, 2008 - The American Academy of Pediatrics (AAP) today issued new cholesterol screening and treatment recommendations for children whose families have high risk for factors cardiovascular disease.

July 7, 2008 - InTouch Technologies Inc. today launched a new product feature, StrokeRESPOND, to extend the functionality of its Remote Presence robotic technology for stroke experts.

July 3, 2008 - A multicenter trial with up to five years of follow-up continues to support the mid- and long-term durability and safety of the Zenith endovascular graft used for aneurysm repair.

July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-away introducers used for placement and implantation of pacemaker leads, were valid and infringed by the FlowGuard and ViaSeal products marketed by Quan Emerteq Corp.

Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.

July 3, 2008 - Boston Scientific Corp. today said the FDA has approved the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease.

The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific. FDA approval clears the way for Boston Scientific to launch the PROMUS Stent immediately in the U.S.

July 2, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional organization for interventional cardiology, has expanded its educational Web site (www.seconds-count.org) with a new section dedicated to health professionals who work with interventional cardiologists and care for patients with cardiovascular disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now